344 related articles for article (PubMed ID: 6230083)
1. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Barry AL; Jones RN; Thornsberry C; Ayers LW; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Barry AL; Jones RN
Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Galante D; Pennucci C; Esposito S; Barba D
Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Grimm H
Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Shah PM; Ottnad-Walz M; Stille W
Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
[TBL] [Abstract][Full Text] [Related]
7. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
11. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
12. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
Esposito S; Galante D; Pennucci C; Barba D
Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
Langsádl L; Menkyna R; Golier J; Silan L
Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
[No Abstract] [Full Text] [Related]
19. Antibacterial activity of norfloxacin.
Norrby SR; Jonsson M
Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activity of AT-2266.
Kouno K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1983 Jul; 24(1):78-84. PubMed ID: 6226242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
